ZIPHIUS
LIVE

Serial Number

79366407

Owner

ZIPHIUS

Attorney

Andrea S. Fuelleman

Filing Date

Mar 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ZIPHIUS Trademark

Serial Number: 79366407 • Registration: 7490625

ZIPHIUS is a trademark filed by ZIPHIUS on March 3, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ZIPHIUS (2 trademarks)

Heidestraat 19

Entity Type: 98

ZIPHIUS VACCINES NV (2 trademarks)

Heidestraat 19

Entity Type: 99

Trademark Details

Filing Date

March 3, 2023

Registration Date

September 3, 2024

Published for Opposition

June 18, 2024

Goods & Services

Downloadable mobile applications and downloadable computer software to enable healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; Downloadable e-commerce software to enable users to perform electronic business transactions via a global computer network; Downloadable computer software to enable professionals to optimize workflow, capture and organize information, place orders and track expenses

Medical services and healthcare services namely, offered through a network of healthcare providers on a contract basis; provision of medical information; provision of medical information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments via the Internet; gene therapy and stem cell therapy services; medical and psychological counselling services; medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes

Pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders, infectious diseases, parasitic diseases, and oncology in the field of cystic Fibrosis, chlamydia trachomatis, eppstein barr, herpes zoster, herpes simplex, coronaviruses, malaria, leishmaniasis, and trypanosomiasis; chikungunya, dengue, lymphatic filariasis, rift valley fever, yellow fever, zika, malaria, Japanese encephalitis, West Nile fever, schistosomiasis (bilharziasis), Onchocerciasis (river blindness), plagues, tungiasis, typhus, louse-borne relapsing fever, Leishmaniasis, Sandfly fever (Phlebotomus fever), Crimean Congo haemorrhagic fever, Lyme disease, Relapsing fever (borreliosis), rickettsial diseases, Tick-borne encephalitis, tularaemia, chagas disease (American trypanosomiasis), sleeping sickness (African trypanosomiasis), all of the foregoing based on self-amplifying RNA and Lipid based delivery vehicles; vaccines

Provision of information and advisory services relating to electronic commerce; provision of customer information on pharmaceutical and medical products through an on-line computer network for advertising purposes

Surgical apparatus and instruments for medical use; blood pressure and diabetic diagnostic medical devices

Scientific research for medical purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 8, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 18, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 18, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 3, 2024 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 28, 2024 ADCH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 14, 2024 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 28, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 28, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 11, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 2, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2023 RFCS
REFUSAL PROCESSED BY MPU
Dec 11, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 7, 2023 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Dec 4, 2023 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 2, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 30, 2023 REPR